FILTER

FILTERED INTERVIEW RESULTS

David Craford

PRESIDENT AND CEO, CYTOBANK
Cytobank is developing and commercializing the leading SaaS platform for machine learning-based analysis of high-complexity life sciences data.

Paul Tanico

CEO, NEURODIAGNOSTICS LLC
NeuroDiagnostics is focused on its DISCERN™ test for the diagnosis of Alzheimer’s disease.

Kevin Grimes

CO-DIRECTOR, SPARK TRANSLATIONAL RESEARCH PROGRAM, STANFORD UNIVERSITY
The Stanford SPARK program was established in 2006 to advance new biomedical research discoveries into promising new treatments for patients.

Louis Lehot

MANAGING PARTNER, DLA PIPER
DLA Piper, one of the largest law firms in the world, has a footprint across 40 juris-dictions and an active life sciences sector team.

Eugene Williams

EXECUTIVE CHAIRMAN, PROMIS
ProMIS Neurosciences is a development-stage biotech company focused on neurodegenerative diseases, particularly Alzheimer’s disease and ALS.

Wu Yifang

CEO, FOSUN PHARMA
Fosun Pharma is a leading pharma company in China with innovative and global ambitions.

Sara Radcliffe

PRESIDENT & CEO, CALIFORNIA LIFE SCIENCES ASSOCIATION
California Life Sciences Association (CLSA) is the trade association representing California’s in-novative life sciences industry, ensuring that it retains its competitive edge.

Dr. Jim Li

CEO, SUNDIA
Sundia is a CRO based in China and speaks to GBR of the evolution of the drug discovery process in China.

Dr. Xu Jia

CONSULTING LEADER, PWC CHINA HEALTHCARE AND PHARMACEUTICALS
PwC in China is benefitting from the rise of the biopharma and a flurry of IPO and acquisition activities in the pharma industry more generally.

Nick Grasman

LEAD MARKET MANAGER, DOW PHARMA SOLUTIONS, THE DOW CHEMICAL COMPANY
Dow Pharma Solutions develops functional excipients and APIs that enable improved pharmaceutical delivery and enhanced solubility.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Latin America Petrochemicals and Chemicals 2024 - Digital Interactive

The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.

PARTNER EVENTS